(CRNC) Cerence - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1567271093
CRNC: AI, Virtual, Assistants, Speech, Recognition, Software, Services
Cerence Inc. (NASDAQ: CRNC) specializes in AI-driven virtual assistant solutions tailored for the automotive and mobility industries, serving markets globally, including the United States, Europe, the Middle East, Africa, and Asia-Pacific. The companys product portfolio includes edge software components, cloud-connected services, virtual assistant coexistence capabilities, and professional services. Its conversational AI solutions encompass speech recognition, natural language understanding, speech signal enhancement, text-to-speech, and acoustic modeling technology. Cerence was spun off from Nuance Communications in 2020 and is headquartered in Burlington, Massachusetts.
From a technical perspective, CRNC is currently trading at $11.61, below its 20-day SMA of $13.25 and 50-day SMA of $12.40, but above its 200-day SMA of $5.77. The stock faces resistance at $14.3 and $20.1, with support levels at $9.1, $7.4, and $3.1. The average 20-day volume is 3,053,750 shares, with an ATR of $1.92, indicating moderate volatility.
Fundamentally, Cerence has a market cap of $542.15 million, with a forward P/E of 243.90 and a P/B ratio of 4.50. The P/S ratio stands at 2.22, reflecting its revenue multiple. The companys RoE is currently not available due to insufficient data.
Additional Sources for CRNC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CRNC Stock Overview
| Market Cap in USD | 413m |
| Sector | Technology |
| Industry | Software - Application |
| GiC Sub-Industry | Systems Software |
| IPO / Inception | 2019-10-02 |
CRNC Stock Ratings
| Growth 5y | -42.1% |
| Fundamental | -14.2% |
| Dividend | 0.0% |
| Rel. Strength | -48.8 |
| Analysts | 3.29/5 |
| Fair Price Momentum | 6.10 USD |
| Fair Price DCF | 6.25 USD |
CRNC Dividends
No Dividends PaidCRNC Growth Ratios
| Growth Correlation 3m | -62.3% |
| Growth Correlation 12m | 33.6% |
| Growth Correlation 5y | -82.7% |
| CAGR 5y | -13.17% |
| CAGR/Max DD 5y | -0.13 |
| Sharpe Ratio 12m | -1.55 |
| Alpha | -66.46 |
| Beta | 2.865 |
| Volatility | 127.17% |
| Current Volume | 1090.3k |
| Average Volume 20d | 1144.4k |
As of April 02, 2025, the stock is trading at USD 7.89 with a total of 1,090,299 shares traded.
Over the past week, the price has changed by -19.98%, over one month by -23.62%, over three months by -0.50% and over the past year by -48.63%.
Neither. Based on ValueRay Fundamental Analyses, Cerence is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -14.15 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRNC as of April 2025 is 6.10. This means that CRNC is currently overvalued and has a potential downside of -22.69%.
Cerence has received a consensus analysts rating of 3.29. Therefor, it is recommend to hold CRNC.
- Strong Buy: 1
- Buy: 0
- Hold: 6
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CRNC Cerence will be worth about 7 in April 2026. The stock is currently trading at 7.89. This means that the stock has a potential downside of -11.91%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 12.6 | 59.4% |
| Analysts Target Price | 7.2 | -8.7% |
| ValueRay Target Price | 7 | -11.9% |